Shoulder Innovations, Inc. (Ticker: SI US) is an American medical technology company specializing in advanced implant systems for the shoulder surgery market. The company's ecosystem includes implant systems, preoperative planning technology, and efficient instruments designed to improve shoulder arthroplasty outcomes. Shoulder Innovations plans to list on the New York Stock Exchange on July 31, 2025. It intends to offer 5 million shares at a price range of $19.00 to $21.00, seeking to raise $100 million at the midpoint price. The IPO implies a market capitalization of approximately $398.5 million. The company aims to address challenges in shoulder surgical care by delivering predictable outcomes and procedural simplicity. Morgan Stanley and Goldman Sachs are among the lead managers.